What's in Laboratorios Goulart S.A.'s pipeline?

Laboratorios Goulart S.A. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Laboratorios Goulart S.A.'s portfolio?

Top competitors by shared drug class: BioPharmX, Inc., Hospital General de Mexicali, National Taiwan University Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/laboratorios-goulart-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Laboratorios Goulart S.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laboratorios Goulart S.A. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Taro Elixir	Taro Elixir	phase 3
oxytetracycline, taro elixir	oxytetracycline, taro elixir	phase 3	tetracycline antibiotic	30S ribosomal subunit	Infectious disease

Therapeutic area mix

Infectious disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

BioPharmX, Inc. · 1 shared drug class
Hospital General de Mexicali · 1 shared drug class
National Taiwan University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Laboratorios Goulart S.A.:

Cite this brief

Drug Landscape (2026). Laboratorios Goulart S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/laboratorios-goulart-s-a. Accessed 2026-05-17.